Post-traumatic Stress, Signs of Depression and Burnout Syndrome Among Nursing Home Staff in Occitanie During the COVID-19 Pandemic
NCT ID: NCT04916275
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
501 participants
OBSERVATIONAL
2021-05-27
2021-10-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hospital Interns Psychological State During the COVID-19
NCT04669054
Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population
NCT04397835
COVID-Impact "Psychological IMPACT of Covid-19 on AP-HP Staff"
NCT04558437
Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak
NCT04374097
Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients
NCT01838798
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Staff working in a nursing home in Occitanie
Cognitive tests
Optional tests: Corsi block-tapping task, Stroop test and Iowa gambling task
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive tests
Optional tests: Corsi block-tapping task, Stroop test and Iowa gambling task
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Professional agreeing to participate
* Professional in a nursing home for at least 3 months
* Professional able to read French
* Profession with an internet connection
Exclusion Criteria
* The subject refuses to participate
* The subject has already been included into the study
* It is impossible to give the subject informed information
* The subject is under safeguard of justice or state guardianship
* The subject is unable to express consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ismaël Conejero
Role: PRINCIPAL_INVESTIGATOR
CHU de Nimes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Montpellier
Montpellier, , France
CHU de Nîmes, Hôpital Universitaire Carémeau
Nîmes, , France
CHU de Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Conejero I, Petrier M, Fabbro Peray P, Voisin C, Courtet P, Potier H, Elotmani L, Lafont B, Lefrant JY, Lopez Castroman J, Arbus C, Blain H. Post-traumatic stress disorder, anxiety, depression and burnout in nursing home staff in South France during the COVID-19 pandemic. Transl Psychiatry. 2023 Jun 15;13(1):205. doi: 10.1038/s41398-023-02488-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03541-38
Identifier Type: OTHER
Identifier Source: secondary_id
Local/2020/COVID/JYL IC-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.